These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 14107974
21. MONOAMINE OXIDASE INHIBITORS, TYRAMINE, AND CHESSE. HORWITZ D, LOVENBERG W, ENGELMAN K, SJOERDSMA A. JAMA; 1964 Jun 29; 188():1108-10. PubMed ID: 14163106 [No Abstract] [Full Text] [Related]
22. CHEESE AND MONOAMINE OXIDASE INHIBITORS. INTERACTION IN ANAESTHETISED CATS. NATOFF IL. Lancet; 1964 Mar 07; 1(7332):532-3. PubMed ID: 14100189 [No Abstract] [Full Text] [Related]
23. HYPERTENSION WITH MONOAMINE OXIDASE INHIBITORS. OGILVIE C. Br Med J; 1964 May 16; 1(5393):1313-4. PubMed ID: 14123646 [No Abstract] [Full Text] [Related]
24. Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs. Blackwell B, Marley E, Price J, Taylor D. Br J Psychiatry; 1967 Apr 16; 113(497):349-65. PubMed ID: 6034391 [No Abstract] [Full Text] [Related]
25. HAZARDS WITH MOMOAMINE-OXIDASE INHIBITORS. TONKS CM, LLOYD AT. Br Med J; 1965 Feb 27; 1(5434):589. PubMed ID: 14243070 [No Abstract] [Full Text] [Related]
26. THE EFFECT OF AMINE OXIDASE INHIBITORS ON PREGNANCY. POULSON E, ROBSON JM. J Endocrinol; 1963 Nov 27; 27():147-55. PubMed ID: 14079506 [No Abstract] [Full Text] [Related]
28. Myocardial Injury from Tranylcypromine-Induced Hypertensive Crisis Secondary to Excessive Tyramine Intake. Salter M, Kenney A. Cardiovasc Toxicol; 2018 Dec 27; 18(6):583-586. PubMed ID: 30083815 [Abstract] [Full Text] [Related]
29. MONOAMINE OXIDASE INHIBITORS. ADVERSE REACTIONS AND POSSIBLE MECHANISMS. GOLDBERG LI. JAMA; 1964 Nov 02; 190():456-62. PubMed ID: 14197995 [No Abstract] [Full Text] [Related]
30. Tranylcypromine (parnate) a new monoamine oxidase inhibitor. LEMERE F. Am J Psychiatry; 1960 Sep 02; 117():249. PubMed ID: 14415582 [No Abstract] [Full Text] [Related]
31. [ANTIDEPRESSIVE TREATMENT WITH MONOAMINE OXIDASE (MAO) INHIBITORS. II. DRUG-THERAPEUTIC INQUIRY ON CEREBROVASCULAR SIDE-EFFECTS, WITH MEDICOLEGAL ASPECTS OF THE USE OF MAO INHIBITORS]. HOLMBERG G, SJOEQVIST F. Sven Lakartidn; 1964 Dec 02; 61():3794-807. PubMed ID: 14276463 [No Abstract] [Full Text] [Related]
32. [ANTIDEPRESSIVE TREATMENT WITH MONOAMINE OXIDASE (MAO) INHIBITORS. I. SIDE-EFFECTS AND RISKS OF POTENTIATION]. HOLMBERG G, SJOEQVIST F. Sven Lakartidn; 1964 Dec 02; 61():3762-93. PubMed ID: 14276462 [No Abstract] [Full Text] [Related]
33. TOXICITY REVERSED: REVERSAL OF IMIPRAMINE-MONOAMINE OXIDASE INHIBITOR INDUCED TOXICITY BY CHLORPROMAZINE. GRANTHAM J, NEEL W, BROWN RW. J Kans Med Soc; 1964 Jun 02; 65():279-80. PubMed ID: 14157699 [No Abstract] [Full Text] [Related]
34. Tranylcypromine in mind (Part I): Review of pharmacology. Ulrich S, Ricken R, Adli M. Eur Neuropsychopharmacol; 2017 Aug 02; 27(8):697-713. PubMed ID: 28655495 [Abstract] [Full Text] [Related]
35. Treatment of MAOI hypertensive crisis with sublingual nifedipine. Clary C, Schweizer E. J Clin Psychiatry; 1987 Jun 02; 48(6):249-50. PubMed ID: 3584082 [Abstract] [Full Text] [Related]
37. Tranylcypromine and trifluoperazine in the management of the menopausal syndrome. MAZZA PA. Dis Nerv Syst; 1962 Apr 07; 23():224-5. PubMed ID: 14471846 [No Abstract] [Full Text] [Related]